Michael Recht
InvestorChair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures
About
A pediatric hematology leader and Professor of Clinical Pediatrics at Yale University School of Medicine, Recht serves as P2C's Chief Medical and Scientific Advisor. He previously was Chief Science Officer at ATHN and directed hemophilia centers at OHSU.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Frequently asked questions
- Who is Michael Recht?
- A pediatric hematology leader and Professor of Clinical Pediatrics at Yale University School of Medicine, Recht serves as P2C's Chief Medical and Scientific Advisor. He previously was Chief Science Officer at ATHN and directed hemophilia centers at OHSU.
- Where does Michael Recht work?
- Michael Recht is Chair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures.